title: [Investigation of Triazavirin antiviral activity against tick-borne encephalitis pathogen in cell culture].
abstract: The efficacy of Triazavirin against the tick-borne encephalitis virus was estimated in the sensitive cell culture vs. the active drug Ribavirin. In a concentration of 128 mcg/ml Triazavirin was shown active in inhibition of the tick-borne encephalitis virus reproduction (strain Sofiin) by accumulation in the SKEV cell culture.
authors: S Ia
authors: SIa
authors: Loginova
authors: S V
authors: SV
authors: Borisevich
authors: V L
authors: VL
authors: Rusinov
authors: U N
authors: UN
authors: Ulomskiĭ
authors: V N
authors: VN
authors: Charushin
authors: O N
authors: ON
authors: Chupakhin
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000138:chemical synthesis / Q000494:pharmacology*; D001393:Azoles / Q000138:chemical synthesis / Q000494:pharmacology*; D002460:Cell Line; D004669:Encephalitis Viruses, Tick-Borne / Q000187:drug effects* / Q000502:physiology; D004847:Epithelial Cells / Q000166:cytology / Q000187:drug effects* / Q000821:virology; D007668:Kidney / Q000166:cytology / Q000187:drug effects* / Q000821:virology; D012254:Ribavirin / Q000494:pharmacology; D013552:Swine; D014227:Triazines / Q000138:chemical synthesis / Q000494:pharmacology*; D014230:Triazoles; D014779:Virus Replication / Q000187:drug effects
chemical_list: D000998:Antiviral Agents; D001393:Azoles; D014227:Triazines; D014230:Triazoles; D012254:Ribavirin; C539416:riamilovir